Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA064709-01A1
Application #
2107359
Study Section
Reproductive Endocrinology Study Section (REN)
Project Start
1996-08-01
Project End
2001-05-31
Budget Start
1996-08-01
Budget End
1997-05-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016
Kleinberg, David L; Ruan, Weifeng; Yee, Douglas et al. (2007) Insulin-like growth factor (IGF)-I controls prostate fibromuscular development: IGF-I inhibition prevents both fibromuscular and glandular development in eugonadal mice. Endocrinology 148:1080-8
Carmichael, John D; Danoff, Ann; Milani, Daniela et al. (2006) GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90. Clin Endocrinol (Oxf) 65:169-77
Ruan, Weifeng; Fahlbusch, Fabian; Clemmons, David R et al. (2006) SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3? Mol Endocrinol 20:426-36
Ruan, Weifeng; Monaco, Marie E; Kleinberg, David L (2005) Progesterone stimulates mammary gland ductal morphogenesis by synergizing with and enhancing insulin-like growth factor-I action. Endocrinology 146:1170-8
Kleinberg, D L; Feldman, M; Ruan, W (2000) IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia 5:17-Jul
Ruan, W; Powell-Braxton, L; Kopchick, J J et al. (1999) Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development. Endocrinology 140:1984-9
Ruan, W; Kleinberg, D L (1999) Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 140:5075-81